Lupin Limited (NSE:LUPIN)
India · Delayed Price · Currency is INR 1,922.90
-40.60 (-2.07%)
Sep 26, 2025, 3:29 PM IST
Lupin Employees
Lupin had 24,006 employees as of March 31, 2025. The number of employees increased by 2,138 or 9.78% compared to the previous year.
Employees
24,006
Change (1Y)
2,138
Growth (1Y)
9.78%
Revenue / Employee
9.74M INR
Profits / Employee
1.54M INR
Market Cap
877.32B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 24,006 | 2,138 | 9.78% |
| Mar 31, 2024 | 21,868 | 935 | 4.47% |
| Mar 31, 2023 | 20,933 | 1,144 | 5.78% |
| Mar 31, 2022 | 19,789 | 1,216 | 6.55% |
| Mar 31, 2021 | 18,573 | 271 | 1.48% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sun Pharmaceutical Industries | 43,000 |
| Divi's Laboratories | 10,542 |
| Cipla | 30,313 |
| Apollo Hospitals Enterprise | 42,497 |
| Mankind Pharma | 26,978 |
| Zydus Lifesciences | 27,917 |
| Fortis Healthcare | 12,237 |
| Alkem Laboratories | 18,785 |
Lupin News
- 3 days ago - Lupin shares edge higher after tentative US FDA approval for HIV drug generic - Business Upturn
- 4 days ago - Lupin gets tentative USFDA approval for HIV treatment drug - Business Upturn
- 8 days ago - Lupin’s Pune Biotech facility receives four observations in U.S. FDA Pre-Approval inspection - Business Upturn
- 11 days ago - Lupin receives U.S. FDA nod for Lenalidomide Capsules - Business Upturn
- 12 days ago - Lupin receives six USFDA observations at Nagpur Injectable facility - Business Upturn
- 25 days ago - Lupin secures USFDA approval for Risperidone long-acting injectable with 180-day exclusivity - Business Upturn
- 5 weeks ago - Natco Pharma launches generic Bosentan tablets for oral suspension in the US with 180-day exclusivity - Business Upturn
- 5 weeks ago - Lupin launches Bosentan Tablets for Oral Suspension in US with 180-day exclusivity - Business Upturn